{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:55:03Z","timestamp":1780419303805,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72074163"],"award-info":[{"award-number":["72074163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72374149"],"award-info":[{"award-number":["72374149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.lanwpc.2024.101088","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T05:23:08Z","timestamp":1715836988000},"page":"101088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative study"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-1535","authenticated-orcid":false,"given":"Jay","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanfang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-6846","authenticated-orcid":false,"given":"Mihajlo","family":"Jakovljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-1476","authenticated-orcid":false,"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lanwpc.2024.101088_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1806930","article-title":"Major events in the life course of new drugs, 2000\u20132016","volume":"380","author":"Beall","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"sup1","key":"10.1016\/j.lanwpc.2024.101088_bib2","first-page":"42","article-title":"Asian innovation in pharmaceutical and medical device industry - beyond tomorrow","volume":"24","author":"Jakovljevic","year":"2021","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.lanwpc.2024.101088_bib3","series-title":"Global oncology trends 2023:outlook to 2027","year":"2023"},{"issue":"6","key":"10.1016\/j.lanwpc.2024.101088_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"Prasad","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"sup1","key":"10.1016\/j.lanwpc.2024.101088_bib5","first-page":"i","article-title":"Therapeutic innovations: the future of health economics and outcomes research - increasing role of the Asia-Pacific","volume":"24","author":"Jakovljevic","year":"2021","journal-title":"J\u00a0Med Econ"},{"issue":"4","key":"10.1016\/j.lanwpc.2024.101088_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40258-017-0307-0","article-title":"Drug pricing in South Korea","volume":"15","author":"Kwon","year":"2017","journal-title":"Appl Health Econ Health Pol"},{"key":"10.1016\/j.lanwpc.2024.101088_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vhri.2021.12.003","article-title":"Policy updates on access to and affordability of innovative medicines in China","volume":"30","author":"Liu","year":"2022","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101088_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004332","article-title":"Price negotiation and pricing of anticancer drugs in China: an observational study","volume":"21","author":"Zhou","year":"2024","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanwpc.2024.101088_bib9","author":"Mamiya"},{"key":"10.1016\/j.lanwpc.2024.101088_bib10","doi-asserted-by":"crossref","first-page":"l4340","DOI":"10.1136\/bmj.l4340","article-title":"New drugs: where did we go wrong and what can we do better?","volume":"366","author":"Wieseler","year":"2019","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.lanwpc.2024.101088_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(20)30139-X","article-title":"Prices and clinical benefit of cancer drugs in the USA and Europe: a cost\u2013benefit analysis","volume":"21","author":"Vokinger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.lanwpc.2024.101088_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2026","article-title":"Analysis of launch and postapproval cancer drug pricing, clinical benefit, and policy implications in the US and europe","volume":"7","author":"Vokinger","year":"2021","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.lanwpc.2024.101088_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40273-022-01161-7","article-title":"Prices and clinical benefit of national price-negotiated anticancer medicines in China","volume":"40","author":"Zhang","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.lanwpc.2024.101088_bib14","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1111\/cas.13831","article-title":"Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan","volume":"109","author":"Satoh","year":"2018","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101088_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41571-023-00728-3","article-title":"Newly approved cancer drugs in China - innovation and clinical benefit","volume":"20","author":"Zhang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"16","key":"10.1016\/j.lanwpc.2024.101088_bib19","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1200\/JCO.2010.34.1248","article-title":"Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice","volume":"29","author":"Trotta","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.lanwpc.2024.101088_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.annonc.2023.06.002","article-title":"ESMO-magnitude of clinical benefit scale for haematological malignancies (ESMO-MCBS:H) version 1.0","volume":"34","author":"Kiesewetter","year":"2023","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.lanwpc.2024.101088_bib25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1377\/hlthaff.2019.01122","article-title":"Lessons from the impact of price regulation on the pricing of anticancer drugs in Germany","volume":"39","author":"Lauenroth","year":"2020","journal-title":"Health Aff"},{"key":"10.1016\/j.lanwpc.2024.101088_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113042","article-title":"Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US","volume":"258","author":"Salas-Vega","year":"2020","journal-title":"Soc Sci Med"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101088_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamaoncol.2016.4166","article-title":"Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines","volume":"3","author":"Salas-Vega","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lanwpc.2024.101088_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107127","article-title":"To curb research misreporting, replace significance and confidence by compatibility: a preventive medicine golden Jubilee article","volume":"164","author":"Greenland","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.lanwpc.2024.101088_bib29","article-title":"P-value, compatibility, and S-value","volume":"4","author":"Mansournia","year":"2022","journal-title":"Glob Epidemiol"},{"key":"10.1016\/j.lanwpc.2024.101088_bib30","series-title":"Ensuring access to medicines: how to redesign pricing, reimbursement and procurement?","author":"Vogler","year":"2018"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101088_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12962-023-00461-9","article-title":"Successes and challenges of China\u2019s health care reform: a four-decade perspective spanning 1985-2023","volume":"21","author":"Jakovljevic","year":"2023","journal-title":"Cost Eff Resour Allocation"},{"issue":"5","key":"10.1016\/j.lanwpc.2024.101088_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/2168479017705157","article-title":"Drugs targeted for price cutting in Japan: the case of price revisions based on the divergence of official versus delivery prices","volume":"51","author":"Fukumoto","year":"2017","journal-title":"Ther Innov Regul Sci"},{"issue":"11","key":"10.1016\/j.lanwpc.2024.101088_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s40273-016-0428-6","article-title":"Competition between biosimilars and patented biologics: learning from European and Japanese experience","volume":"34","author":"Bocquet","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.lanwpc.2024.101088_bib34","article-title":"The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis","volume":"32","author":"Luo","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"10.1016\/j.lanwpc.2024.101088_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cts.13161","article-title":"Analysis of the Korean generic medicine market: factors affecting the market share of generic medicines","volume":"15","author":"Kim","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"9798","key":"10.1016\/j.lanwpc.2024.101088_bib36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(11)61098-2","article-title":"Future of Japan\u2019s system of good health at low cost with equity: beyond universal coverage","volume":"378","author":"Shibuya","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101088_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1470-2045(15)00564-1","article-title":"Price, value, and the cost of cancer drugs","volume":"17","author":"Fojo","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.lanwpc.2024.101088_bib38","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/curroncol30020137","article-title":"Correlation of anticancer drug prices with outcomes of overall survival and progression-free survival in clinical trials in Japan","volume":"30","author":"Okabe","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.lanwpc.2024.101088_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vhri.2019.11.008","article-title":"International experience in therapeutic value and value-based pricing: a rapid review of the literature","volume":"23","author":"Prieto-Pinto","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"9","key":"10.1016\/j.lanwpc.2024.101088_bib40","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jval.2021.04.1278","article-title":"Drug prices and value of oncology drugs in Italy","volume":"24","author":"Russo","year":"2021","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.lanwpc.2024.101088_bib41","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdy449","article-title":"Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016","volume":"29","author":"Marandino","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.lanwpc.2024.101088_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrd3501","article-title":"Bridging the efficacy-effectiveness gap: a regulator\u2019s perspective on addressing variability of drug response","volume":"10","author":"Eichler","year":"2011","journal-title":"Nat Rev Drug Discov"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:54:35Z","timestamp":1778921675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606524000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"alternative-id":["S2666606524000828"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101088","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101088"}}